Want to join the conversation?
$HON 2Q15 Q&A: Davis of Barclays Capital asked about how macro lines up with guidance. David explained that it’s generally slow 1Q for everyone regarding sales growth. Things have improved a bit since that time. It’s slightly better than it was, but it’s still not a boomlet.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?